3.3. Association between Immune Seroresponses and Fecal Shedding of Rotavirus among Placebo Recipients
Anti-P2-VP8-P[8] IgA, anti-RV IgA, and anti-P2-VP8-P[8] IgG seroresponses as well as NAb seroresponses to Wa and 89-12 strains among placebo recipients were relatively low at the Day 84 timepoint and there were no significant differences in seroresponses between shedders and non-shedders (Among placebo recipients, there were no significant differences in anti-P2-VP8-P[8] IgA, anti-RV IgA, anti-P2-VP8-P[8] IgG or NAb titers between shedders and non-shedders at baseline or the Day 84 time point (